ARCHIVES

Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC

This article is from The Cancer Letter archive.

Vol. 25 No. 33 | September 3, 1999

Download PDF Visit The Full Archive

Related Articles

Funding and Direction of IL-2/LAK Trials Questioned By DCT Board

March 3, 1989

Professional Society Growth Obvious At Spring Meetings; AACR Looking To Broaden Its Base

June 5, 1987

NCI Extramural Program: Advisors Approve Concepts For Diagnostic Imaging Trials Group

March 21, 1997

Statins Associated With Lower Risk Of High-Grade Prostate Cancer

March 25, 2011

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

October 16, 1992

Gene Therapy Hyped By Scientists, Panel Tells NIH; Emphasis Must Be Basic Research

December 15, 1995